Abcellera Biologics Inc
NASDAQ:ABCL
Abcellera Biologics Inc
Cash from Investing Activities
Abcellera Biologics Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Cash from Investing Activities
-$221.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-111%
|
CAGR 10-Years
N/A
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Cash from Investing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Cash from Investing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovotech Inc
XTSX:IOT
|
Cash from Investing Activities
-CA$58.4k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-19%
|
See Also
What is Abcellera Biologics Inc's Cash from Investing Activities?
Cash from Investing Activities
-221.1m
USD
Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Cash from Investing Activities amounts to -221.1m USD.
What is Abcellera Biologics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-111%
Over the last year, the Cash from Investing Activities growth was 37%. The average annual Cash from Investing Activities growth rates for Abcellera Biologics Inc have been -23% over the past three years , -111% over the past five years .